Search Results - Ashu, Alda

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    CTIM-23. SAFETY RUN-IN RESULTS OF A PHASE I/II STUDY TO EVALUATE ATEZOLIZUMAB IN COMBINATION WITH CABOZANTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

    CTIM-23. SAFETY RUN-IN RESULTS OF A PHASE I/II STUDY TO EVALUATE ATEZOLIZUMAB IN COMBINATION WITH CABOZANTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA by Weathers, Shiao-Pei, Kamiya-Matsuoka, Carlos, Majd, Nazanin, Ashu, Alda, Thompson, Chantell, Gachimova, Evguenia, Aaroe, Ashley, Patel, Chirag, Loghin, Monica, O'Brien, Barbara, Alfred Yung, W K, Puduvalli, Vinay, de Groot, John

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    A Dose Escalation Study of RP6530, a Novel Dual PI3K δ/γ Inhibitor, in Patients with Relapsed/Refractory T-Cell Lymphoma

    A Dose Escalation Study of RP6530, a Novel Dual PI3K δ/γ Inhibitor, in Patients with Relapsed/Refractory T-Cell Lymphoma by Oki, Yasuhiro, Huen, Auris, Barde, Prajak J, Penmetsa, Kumar, Ashu, Alda, Pullokaran, Little, Wilson, Carol, Viswanadha, Srikant, Duvic, Madeleine

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: